You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myeloid, Acute

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Antalya

Recruiting
  • Acute Myeloid Leukemia
    • Antalya, Turkey
      Antalya Training and Research Hospital
    Jul 29, 2023

    Frequency and Risk Factors of Acute Myeloid Leukemia

    Not yet recruiting
    • Myeloid Leukemia
    • Bone marrow aspirite for diagnosis
    • (no location specified)
    Mar 15, 2023

    Patients With Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia, Adult
      • Freiburg, CA, Germany
        Medical Center- University of Freiburg
      Aug 4, 2023

      AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

      Not yet recruiting
      • AML
      • +11 more
      • (no location specified)
      Aug 14, 2023

      Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Mitoxantrone hydrochloride liposome injection
      • +3 more
      • (no location specified)
      May 29, 2023

      Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

      Recruiting
      • Acute Myeloid Leukemia
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jun 23, 2023

      Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Minimal Residual Disease
        • Chapel Hill, North Carolina
          North Carolina Cancer Hospital (NCCH)
        Feb 2, 2023

        Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)

        Recruiting
        • Leukemia, Myeloid, Acute
        • Chengdu, Sichuan, China
          West China Hospital of Sichuan University
        Dec 27, 2022

        Acute Myeloid Leukemia Trial in Taipei

        Enrolling by invitation
        • Acute Myeloid Leukemia
          • Taipei, Taiwan
            National Taiwan University Hospital
          Aug 9, 2023

          Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Mitoxantrone hydrochloride liposome injection
          • +3 more
          • Tianjin, China
            Institute of Hematology & Blood Diseases Hospital
          Jul 1, 2023

          PET Tracer Based FDG Signal for Predicting Prognosis in Acute

          Enrolling by invitation
          • Acute Myeloid Leukemia
          • No intervention
          • Guangzhou, Guangdong, China
            First Affiliated Hospital of Jinan University
          Jun 22, 2023

          Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

          Not yet recruiting
          • Chemotherapy-Induced Thrombocytopenia
          • Hetrombopag Olamine
          • (no location specified)
          Jul 5, 2023

          Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Beijing, Beijing, China
            Yuan Kong
          Sep 4, 2023

          GilteRInf 2022 Study (Gilteritinib Related Infections)

          Active, not recruiting
          • Acute Myeloid Leukemia
          • Roma, RM, Italy
            Maria Ilaria Del Principe
          Mar 17, 2023

          Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

          Recruiting
          • Acute Myeloid Leukemia
          • Suzhou, Jiangsu, China
            Qiu Huiying
          Mar 28, 2023

          Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

          Recruiting
          • Relapsed/Refractory Acute Myeloid Leukemia
          • B7-H3 target, CAR gene modified gdT cell injection
          • Hangzhou, Zhejiang, China
            The First Affiliated Hospital， Zhejiang University School of Med
          Feb 15, 2023

          Leukemia, Myeloid, Acute Trial in Baltimore (Flotetuzumab)

          Not yet recruiting
          • Leukemia, Myeloid, Acute
          • Baltimore, Maryland
            Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
          Aug 16, 2022

          MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

          Not yet recruiting
          • Myelodysplastic Syndromes
          • +3 more
          • Subcutaneous azacitidine
          • Oral decitabine/cedazuridine
          • Newcastle, New South Wales, Australia
            Calvary Mater Newcastle
          May 29, 2023

          Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)

          Recruiting
          • Acute Myeloid Leukemia
          • CIML-NK Cells
          • Cincinnati, Ohio
            Cincinnati Children's Hospital Medical Center
          Jan 4, 2023

          Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Venetoclax)

          Not yet recruiting
          • Leukemia, Myeloid, Acute
          • Guanzhou, Guandong, China
            Nanfang Hospital of Southern Medical University
          Jul 22, 2022

          Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

          Recruiting
          • Refractory/Relapse Acute Myeloid Leukemia
          • Kunming, Yunnan, China
            Department of Hematology,920th Hospital of Joint Logistic Suppor
          Mar 28, 2023

          Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

          Recruiting
          • Acute Myeloid Leukemia
          • +2 more
          • Miami, Florida
            University of Miami
          Dec 22, 2022

          Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)

          Recruiting
          • Acute Myeloid Leukemia
          • Beijing, Beijing, China
            Chinese PLA General Hospital
          Dec 13, 2022

          Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

          Active, not recruiting
          • Acute Myeloid Leukemia
          • +5 more
          • Duarte, California
            City of Hope Medical Center
          Jan 4, 2023

          Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

          Recruiting
          • Acute Myeloid Leukemia
          • +3 more
          • CD123 targeted CAR-NK cells
          • Taiyuan, Shanxi, China
            Shanxi Bethune Hospital
          Aug 28, 2023